Skip to content

Clinical trials

Phase 1 Small Cell Lung Carcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Country / region: Poland Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20181
20191
20211
20231
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting3
Completed3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Boehringer Ingelheim2
Aileron Therapeutics, Inc.1
AstraZeneca1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
MacroGenics1
Pfizer1
Rhizen Pharmaceuticals SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma12
Carcinoma, Non-Small-Cell Lung3
Bites and Stings1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Neuroendocrine1
Cholangiocarcinoma1
Hematologic Neoplasms1
Lymphoma, Follicular1
Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.